Skip to Content

Tag: Financial Results


Dan Starck

Providers

Apria increases full year guidance

May 17, 2021HME News Staff

INDIANAPOLIS – Apria reported net revenue of $275.3 million for the first quarter of 2021, a 2% increase compared to the same period last year.  It reported a net income of $4.5 million, a 29% decrease.  “We delivered strong first quarter 2021 results ahead of our expectations on all three of our key metrics and we built on momentum from 2020 establishing a solid foundation for future growth,” said Dan Starck, CEO. “The country experienced a significant surge...

Apria, COVID-19, Financial Results


Read Full Articlered right arrow icon

Casey Hoyt

Specialty Providers

Viemed sees patient uploads rebound in March

May 4, 2021HME News Staff

LAFAYETTE, La. – Viemed Healthcare reported net revenues for its core business were $25.5 million for the first quarter ended March 31, 2021, a 12% increase compared to the same quarter last year.  Total revenues were $28.4 million, including $2.9 million for contract tracing services and product sales related to the COVID-19 pandemic.  “The first quarter will very likely be the quarter where things began to reopen from the COVID-19 pandemic and I am once again...

COVID-19, Financial Results, Respiratory Therapy, Viemed Healthcare


Read Full Articlered right arrow icon

Providers

Protech Home Medical reports ‘robust’ financial results

March 2, 2021HME News Staff

CINCINNATI – Protech Home Medical reported revenue of $22.8 million for the first quarter of fiscal year 2021, a 32% increase compared to the same period in 2020.  Adjusted EBITDA was $5.1 million vs. $3.3 million, a 53% increase.  “The momentum across the business continues to be robust as evidenced by our first quarter financial and operating results, and I am pleased to saw that we are seeing similar strong trends into our second quarter,” said CEO and Chairman...

Financial Results, Protech Home Medical, Respiratory Therapy


Read Full Articlered right arrow icon

Oventus reports significant growth

Also Noted

Oventus reports significant growth

February 22, 2021HME News Staff

BRISBANE, Australia – Oventus Medical has booked revenues of $550,232 for the six-month period ended Dec. 31, a 192% increase over the prior period. The company credits growth driven by lab-in-lab sites that remained operational during the pandemic, continuing to scan patients; an expansion of the telehealth extension of the lab-in-lab program; and an increase in direct sales to dentists who delivered treatments in their own practices, as well as through lab-in-lab programs. “We...

Financial Results, Obstructive Sleep Apnea, Oventus Medical, Telehealth


Read Full Articlered right arrow icon

Providers

Great Elm set to resume ‘more active acquisitions’

February 16, 2021HME News Staff

WALTHAM, Mass. – Great Elm Group reported $14.5 million in total revenue for DME for the three months ended Dec. 31, a 1% increase compared to the same period last year.  It reported a net loss of $2.9 million vs. $700,000.  “DME was able to grow revenue during the quarter despite the continued negative impact of COVID-19 on its business,” said Peter Reed, CEO. “Profitability was depressed during the quarter primarily as a result of legacy revenue reserve issues...

Financial Results, Great Elm Group


Read Full Articlered right arrow icon

Providers

Protech reports ‘robust’ results

February 1, 2021HME News Staff

CINCINNATI – Protech Home Medical reported revenue of $25 million for the fourth quarter of its fiscal year 2020 compared to $19.5 million for the same period the previous year. It reported revenue of $97.8 million for the year vs. $81 million for 2019, a 21% increase.  Adjusted EBIDTA for the fourth quarter was $5.9 million vs. $3.5 million year over year, and for 2020, $20.8 million vs. $14.8 million year over year.  “Our...

Financial Results, Protech Home Medical


Read Full Articlered right arrow icon

Jim ResMed

Vendors

ResMed on POCs: ‘We don’t need (them)’

January 29, 2021Liz Beaulieu, Editor

SAN DIEGO – ResMed incurred a $13.9 million restructuring expense in the second quarter of its fiscal year 2021 as a result of closing its portable oxygen concentrator business.  The company stopped selling its Mobi POCs in November.  “Going forward, the cessation of the POC business will have an immaterial impact on both group revenue and earnings per share,” said Brett Sandercock, CFO, during a conference call on...

Financial Results, POC, Portable Oxygen Concentrators, ResMed


Read Full Articlered right arrow icon

ResMed posts ‘solid’ quarter

Vendors

ResMed posts ‘solid’ quarter

January 29, 2021HME News Staff

SAN DIEGO – ResMed reported revenues increased to $800 million for the three months ended Dec. 31, 2020, a 7% increase compared to the same period in 2019.  Net income was $179.5 million vs. $160.6 million.  “Our second quarter results reflect continued solid performance and positive trends across our business, resulting in top-line growth,” said Mick Farrell, CEO. “In our core markets of sleep apnea, COPD and asthma, we are seeing continued sequential improvement...

CPAP, Financial Results, ResMed, Sleep Therapy


Read Full Articlered right arrow icon

Lewis Gradon

Vendors

F&P sees increased demand due to COVID-19 surges 

January 22, 2021HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reports operating revenue for the nine months ended Dec. 31, 2020, was up 73% in constant currency compared to the prior comparable period.  In the hospital product group, operating revenue was up 113%, with hardware growing 446% and consumables growing 54%.  “In many parts of the world, we have continued to see an influx of COVID-19 patients requiring hospitalization for respiratory treatment,” said Lewis Gradon,...

Coronavirus Outbreak, Financial Results, Fisher & Paykel Healthcare, nasal high flow therapy, osa, Sleep Therapy


Read Full Articlered right arrow icon

Vendors

F&P Healthcare tracks 'surge'

December 1, 2020HME News Staff

LAGUNA HILLS, Calif. - Fisher & Paykel Healthcare reported operating revenue of $226.2 million for the first half of the 2021 financial year for its homecare product group, a 5% increase compared to the same period in the previous financial year. “Since the pandemic started, many sleep clinics have been closed, resulting in a reduction in new patient diagnoses,” said Lewis Gradon, managing director and CEO. “Our F&P Evora and F&P Vitera masks for OSA are great products that...

Financial Results, Fisher & Paykel Healthcare, respiratory products


Read Full Articlered right arrow icon